6-Bromo-7-chloroquinazoline-2,4-diol is primarily utilized in pharmaceutical research and development. It serves as a key intermediate in the synthesis of various biologically active compounds, particularly those targeting kinase enzymes. Its structure is often modified to create potential drug candidates for treating cancers, as kinase inhibitors play a critical role in regulating cell growth and proliferation. Additionally, it is explored in the development of antimicrobial agents due to its potential to disrupt essential cellular processes in pathogens. Researchers also study its derivatives for their potential applications in treating inflammatory and autoimmune diseases. Its versatility makes it a valuable building block in medicinal chemistry.